Over 5 million people die annually from trauma, tragically threatening the lives of millions more.
Shock Therapeutics Biotechnologies, Inc. was founded by Donald Gann M.D. to bring to market a revolutionary new approach to shock treatment, which preclinical evidence suggests may significantly extend the opportunity to provide critical care. Backed by an innovative team ready to tackle the challenges ahead, STBI is positioned to revolutionize the treatment of shock.
We are currently seeking angel and seed investment and strategic partners to help us complete preclinical development of our novel therapeutic over the next 2-3 years in preparation for clinical trials.
Feel free to contact us at info@shockbiotech.com to learn more!
*Notice: content and communication through Shock Therapeutics Biotechnoloiges, Inc. social media are not an offer to buy securities. Investment opportunities are open to accredited investors only*
Company Details
- Employees
- 2
- Founded
- -
- Address
- 1100 Wicomico St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- shockbiotech.com
- Keywords
- Biotechnology, Shock Trauma, Hemorrhagic Shock, Septic Shock, Cardiogenic Shock, Emergency Medicine, Trauma Surgery, Infectious Disease, Cardiology, Immunology, Endocronology, Biomedical Engineering, Therapeutic Medicine, Antibody Development.
- HQ
- Baltimore, Maryland
Shock Therapeutics Biotech Questions
Shock Therapeutics Biotech's website is shockbiotech.com
Shock Therapeutics Biotech's LinkedIn profile is https://www.linkedin.com/company/shockbiotech
Shock Therapeutics Biotech has
2 employees.
View email and phone details for 2
employees at Shock Therapeutics Biotech.
Shock Therapeutics Biotech's industry is
Biotechnology Research
Shock Therapeutics Biotech's top competitors are
De-Bi, Co.,
Vitrovivo Biotech, Llc,
Nka Bio (Techstars '24),
Herniaid,
Springwear,
Team Med Ventures,
Mastods Clinical Research,
Victorium Clinical Research,
Portal Bioscience Llc,
Test-Point Biomedical Services, Llc.
Shock Therapeutics Biotech's categories are Biotechnology Research
Shock Therapeutics Biotech's founding year is 2017
